K27/G34 versus K28/G35 in histone H3-mutant gliomas: A note of caution

This publication has 11 references indexed in Scilit:

• cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant
  Acta Neuropathologica, 2018
• Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures
  The Oncologist, 2017
• EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas
  Nature Medicine, 2017
• The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
  Acta Neuropathologica, 2016
• Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes
  Acta Neuropathologica, 2015
• Specific detection of methionine 27 mutation in histone 3 variants (H3K27M) in fixed tissue from high-grade astrocytomas
  Acta Neuropathologica, 2014
• Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria
  Neuro-Oncology, 2014
• Standard Mutation Nomenclature in Molecular Diagnostics
  The Journal of Molecular Diagnostics, 2007
• Mutations of the BRAF gene in human cancer
  Nature, 2002
• Amino-acid Sequence of Slightly Lysine-rich Histone
  Nature, 1970